Journals / Medical Network Klinik Bilimler ve Doktor / 2005 / Cilt: 11 - Sayı: 6

A temporal arteritis case with improvement of visual symptoms after corticosteroid theraphy

Kortikosteroid tedaviyle görme fonksiyonlarında düzelme sağlanan bir temporal arterit olgusu

Pages
589–592
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a female patient with temporal arteritis who was admitted to hospital because of sudden visual loss, and who responded to Corticosteroid treatment with an increase in visual acuity, and of visual field, despite optical atrophy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Temporal arteritis is a chronic vasculitis of large and medium-sized vessels.
📊
Key Findings & Data:Patients are usually admitted to hospital because of fever, scull tenderness and headache.Rarely the first symptoms are visual symptoms.
💡
Conclusion & Impact:We present a female patient with temporal arteritis who was admitted to hospital because of sudden visual loss, and who responded to Corticosteroid treatment with an increase in visual acuity, and of visual field, despite optical atrophy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Temporal arterit · Görme · Trombositoz

Abstract

Temporal arteritis is a chronic vasculitis of large and medium-sized vessels. Patients are usually admitted to hospital because of fever, scull tenderness and headache.Rarely the first symptoms are visual symptoms. We present a female patient with temporal arteritis who was admitted to hospital because of sudden visual loss, and who responded to Corticosteroid treatment with an increase in visual acuity, and of visual field, despite optical atrophy.

Özet

Temporal arterit orta ve büyük arterleri tutan kronik bir vaskülittir. Hastalar doktora sıklıkla ateş, kafa derisinde hassasiyet, başağrısı ile başvururlar. Nadiren görme ile ilgili semptomlar ilk bulgu olarak karşımıza çıkar.Biz burada ani görme kaybı ile başvuran, optik atrofi gelişmiş olmasına rağmen kortikosteroid tedavi sonrasında görme alanında genişleme ve görme keskinliğinde artış saptadığımız temporal arteritli bir vakayı sunmaktayız.

🔖

Cite This Article

DALBELER, G. A., GÜZELBULUT, F., ERYILMAZ, K. M., EĞİNÇ, D. B., YÜCEL, Ö., DAĞAR, A. (2005). A temporal arteritis case with improvement of visual symptoms after corticosteroid theraphy. Medical Network Klinik Bilimler ve Doktor, Cilt: 11 - Sayı: 6, 589–592. https://ajindex.com/articles/278451

References (9)

  1. Hutchinson J. On a peculiar form of thrombotic arteritis of the aged which sometimes productive of gangrene. Arch Surg 1890;1:323-9
  2. Salvaroni C, Cantini F, Boiardi L, Hunder GG. Polymyalgia Rheumatica and giant cell arteritis. N Engl J Med 2002;347-4:261-71
  3. Toh ML, Wicks IP. Visual loss as presenting feature of giant cell arteritis. Aust N J Med 2000; 30:734
  4. Miller NR. Visual manifestations of temporal arteritis. Rheum Dis Clin North Ann 2001; 27:781-97
  5. İlker SS, Kurt E, Kayıkçıoğlu ÖR. Temporal arterite bağlı santral retinal arter tıkanıklığı. MN-Oftalmoloji Dergisi. 2003;10:280-2
  6. Calgüneri M.Çobankara V.Özatlı D ve ark. Is visual loss due to giant cell arteritis reversible? Yonsei Med J 2003; 44:155-8
  7. Foroozan R, Danesh-Meyer H, Savino PJ, Gamble G,Mekari-Sabbagh ON, Sergott RC. Thrombocytosis in patients with biopsy proven giant cell arteritis. Ophtalmology 2002;109:1267-71
  8. Lincoff NS, Erlich PD, Brass LS. Thrombocytosis in temporal arteritis in temporal arteritis rising platelet counts:a red flag for giant cell arteritis. J Neuroophthalmol 2000; 20:67-72
  9. Liozon E, Herrmann F, Ly K.Robert PY, Loustaud V, Soria P,Vida E. Risk factors for visual loss in giant cell (temporal)arteritis: a prospective study of 174 patients. Am J Med 2001;111:211-7. 10.Ray-Chaudri N, Kine DA, Tijani SO, et al. Effect of prior steroid treatment on temporal arter biopsy findings in giant cell arteritis. Br J Ophthalmol 2002; 86:530-2. 11.Dinowitz M, Leen JS, Hameed M, Walonsky L, Frohman L. Sudden painless visual loss. Surv Ophthalmol 2001; 46:143-8. 12.Nordborg E, Nordborg C. Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology (Oxford) 2003; 42:413-21. 13.Hoffman GS, Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener's Granülamatosis with glucocorticoids and methotrexate. Arthritis Rheum 1992; 35:1322-9. 14.Hoffman GS.Leavitt RY.Kerr GS,Rotten M.Sneller MC,Fauci AS. Treatment of glucocorticoid-resistant or relapsing takayasu arteritis with methotrexate. Artritis Rheum 1994; 37:578-82. 15.Jover JA, Hemandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001; 134:106-14. 16.Hoffmann GS.Cid MC, Hellmann DB et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant